Ramandeep Rattan

Has grant

Senior Scientist

Henry Ford Hospital
Country flagUnited States
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Recent Grants

Grant: Close

Determining the mechanisms by which calorie restriction alter macrophage polarization to promote an anti-tumor environment in epithelial ovarian cancer

Open Date:

Close Date:

Grant: Close

Targeting Mitochondrial Metabolism in Ovarian Cancer.

Open Date:

Close Date:

Articles (29)

(A) DEGs in BRCA2null vs BRCA1null 4T1 mouse breast cancer cell line reported as log fold-change (logFC); red bars are upregulated and blue bars are downregulated; (B) Perturbation analysis of Wnt signaling pathway comparing BRCA2null vs BRCA1null 4T1 mouse breast cancer cell line; red genes are predicted to be upregulated and blue genes are predicted to be downregulated.

Year:

2025

(A) qPCR analysis of Wnt inhibitors Dkk1, Notum, and Axin2 in ID8 mouse ovarian cancer cells. Data are presented as mean +/- SEM (n=3). Ordinary one-way ANOVA with Dunnett’s multiple comparison test was used to calculate statistical significance; (B) Western blot analysis validates upregulation of Axin2 upon loss of BRCA2.

Year:

2025

Nuclear and cytoplasmic green fluorescence were measured in all cells from cultures represented in Figure 3C using image J. Nuclear (left panel) and cytoplasmic (right panel) quantifications are reported separately for each cell line. Statistical significance between control and treated cultures was not achieved.

Year:

2025

Characterization of the Wnt signaling pathway in isogenic mouse ovarian cancer cells upon loss of Brca1 or Brca2. Cellular fractionation was performed to separate cytoplasmic ( A ) and nuclear ( B ) fractions in control no-treatment cells or cells treated with 100 ng/mL Wnt3A for 8 hours; ILF3 and Cox-IV were used as integrity controls for nuclear and cytoplasmic fractions, respectively. C, Levels and cellular location of β-catenin were determined by immunofluorescence for β-catenin (green). DAPI nuclear staining is shown in blue. Images show both green and DAPI channels; white arrows show increased green staining in the nucleus after Wnt3A treatment in ID8 Trp53−/− ; the red arrow shows increased green staining in the cytoplasm after Wnt3A treatment in ID8 Trp53−/− ; Brca1−/− ; yellow arrows show membranal staining in ID8 Trp53−/− ; Brca2−/− ; images shown are specific foci in the cultures. D, Levels of canonical Wnt/β-catenin gene targets were determined by Western blot analysis using whole-cell lysates. The red box shows truncated forms of Tcf1/7. DAPI, 4′,6′-diamidino-2-phenylindole.

Year:

2025

(A) DEGs in BRCA2null vs BRCA1null 4T1 mouse breast cancer cell line reported as log fold-change (logFC); red bars are upregulated and blue bars are downregulated; (B) Perturbation analysis of Wnt signaling pathway comparing BRCA2null vs BRCA1null 4T1 mouse breast cancer cell line; red genes are predicted to be upregulated and blue genes are predicted to be downregulated.

Year:

2024

Nuclear and cytoplasmic green fluorescence were measured in all cells from cultures represented in Figure 3C using image J. Nuclear (left panel) and cytoplasmic (right panel) quantifications are reported separately for each cell line. Statistical significance between control and treated cultures was not achieved.

Year:

2024

(A) qPCR analysis of Wnt inhibitors Dkk1, Notum, and Axin2 in ID8 mouse ovarian cancer cells. Data are presented as mean +/- SEM (n=3). Ordinary one-way ANOVA with Dunnett’s multiple comparison test was used to calculate statistical significance; (B) Western blot analysis validates upregulation of Axin2 upon loss of BRCA2.

Year:

2024

Nuclear and cytoplasmic green fluorescence were measured in all cells from cultures represented in Figure 3C using image J. Nuclear (left panel) and cytoplasmic (right panel) quantifications are reported separately for each cell line. Statistical significance between control and treated cultures was not achieved.

Year:

2024

(A) DEGs in BRCA2null vs BRCA1null 4T1 mouse breast cancer cell line reported as log fold-change (logFC); red bars are upregulated and blue bars are downregulated; (B) Perturbation analysis of Wnt signaling pathway comparing BRCA2null vs BRCA1null 4T1 mouse breast cancer cell line; red genes are predicted to be upregulated and blue genes are predicted to be downregulated.

Year:

2024

(A) qPCR analysis of Wnt inhibitors Dkk1, Notum, and Axin2 in ID8 mouse ovarian cancer cells. Data are presented as mean +/- SEM (n=3). Ordinary one-way ANOVA with Dunnett’s multiple comparison test was used to calculate statistical significance; (B) Western blot analysis validates upregulation of Axin2 upon loss of BRCA2.

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Collaborators (6)

Zhanjun Hou

Professor (Research)

Wayne State University

UNITED STATES
View details

Radhika Gogoi

-

UNITED STATES
View details

Ayesha Alvero

Professor

Wayne State University

UNITED STATES
View details

Gil Mor

Director/Professor

Wayne State University

UNITED STATES
View details

Rouba Ali-Fehmi

Professor, Breast Pathology, Gynecologic Pathology

University of Michigan

UNITED STATES
View details

Seongho Kim

Professor of Biostatistics

Wayne State University School of Medicine

UNITED STATES
View details